�������

News from ������� Langone Health

Black-Colored Plastic Used For Kitchen Utensils And Toys Linked To Banned Toxic Flame Retardants. (CNN)

(6/5) A study published in Chemosphere has found alarming levels of toxic flame retardants, such as decabromodiphenyl ether, in black-colored plastic consumer products, raising concerns about recycling practices and potential health risks, with Leonardo Trasande, MD, the Jim G. Hendrick, M.D. Professor of Pediatrics, vice chair of research in the Department of Pediatrics, professor, Department of Population Health, who was not involved with the study, saying, “I’m not aware of any safe level of brominated flame retardants.”

Why Does Amazon Want To Scan Your Palm At The Doctor’s Office? (Vox)

(6/5) Amazon One’s palm-scanning technology, initially launched in Amazon Go stores in 2020, is now available for patient check-ins at �����о��� Langone Health as of March, raising privacy concerns about data sharing across Amazon’s various business units, while Arielle Sklar, spokesperson, said, “We do not share personal information with Amazon One, and Amazon One does not store any protected health information.”

Medical Debt Crisis: Are Inconsistent Hospital Policies Putting Patients At Risk? (HIT Consultant)

(6/6) A report by the Lown Institute reveals inconsistencies in financial assistance and collection practices across 2,500 U.S. hospitals, including �����о��� Langone Health’s Tisch Hospital in New York City, where a family of three earning $100,000 qualifies for free care, unlike at NewYork-Presbyterian, where the threshold is $53,000; these disparities, stemming from the absence of federal standards, lead to confusion and potential medical debt, with 87% of hospitals offering free care, 83% offering discounted care, and 59% allowing aggressive collection actions, prompting the institute to propose policy changes to standardize eligibility and restrict collection practices.

US Seniors Nearly Double Cannabis Use In Just Two Years, Study Finds. (Forbes)

(6/5) A study published in JAMA Internal Medicine by researchers from the University of California and �����о��� Langone Health found that monthly cannabis use among U.S. adults aged 65 and older increased from 4.8% in 2021 to 7% in 2023, attributed to increased legal access and awareness of medical programs, with Joseph J. Palamar, MPH, PhD, associate professor, Department of Population Health, saying, “It shouldn’t be surprising that use is becoming increasingly more common among people who live in states that allow medical cannabis, which could be due to increased availability or social acceptability.”

(6/5) Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, in an opinion piece, writes, “The last thing we need among our cherished older people who are trying to hang on to optimal functioning as long as possible is something addicting that actually pushes them in the direction of suboptimal performance.”

National Psoriasis Foundation Gala To Honor Joel M. Gelfand, MD. (Healio)

(6/5) The National Psoriasis Foundation will host its annual Commit to Cure gala on June 18 at Cipriani 42nd Street in New York City, honoring Joel M. Gelfand, MD, MSCE, FAAD, Carol Ostrow, and Jose U. Scher, MD, the Steere Abramson Professor of Medicine, Department of Medicine, Division of Rheumatology.

Osteoarthritis Drawing ‘Long Overdue’ Excitement, But Disease Modification Still Elusive. (Healio)

(6/5) Osteoarthritis research is expanding, with experts discussing challenges in developing disease-altering treatments beyond NSAIDs and analgesics; Yusuf Yazici, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, highlighted the potential of lorecivivint to modify disease progression by targeting specific kinases involved in cartilage degradation, though its approval for disease modification remains uncertain, and IL-1 inhibitors show promise in clinical trials for pain relief and functional improvement in knee OA.

Excessive Oleic Acid, Found In Olive Oil, Drives Fat Cell Growth. (Technology Networks)

(6/6) A study published in Cell Reports by researchers, including those from ������� Grossman School of Medicine, found that a high-fat diet rich in oleic acid, common in olive oil, could promote obesity more than other dietary fats, showing that oleic acid increases the number of precursor cells forming new fat cells by enhancing AKT2 signaling and decreasing LXR activity.

A New Test Might Be Able To Detect Your Preeclampsia Risk. (What To Expect)

(6/5) A new blood test called Encompass, developed by Mirvie, offers a promising method to assess preeclampsia risk by analyzing RNA to evaluate placental health, but it is not FDA-approved, costs $1,850, and may not be covered by insurance; Taraneh Shirazian, MD, associate professor, Department of Obstetrics & Gynecology, Division of Global and Community Women's Health said, “Any blood test that would help us to be able to risk-stratify patients is important for prevention,” while also acknowledging the test’s cost as a barrier, stating, “The majority of women in the U.S. cannot afford a $1,850 test,” emphasizing the need for cost-effective solutions to make such advancements equitable.

The Performance Supplement Actually Worth Taking – And The One You Can Definitely Skip. (Women's Health)

(6/5) Nicole Lund, MPH, RDN, clinical nutritionist, Department of Rehabilitation Medicine, Sports Performance Center emphasizes the importance of proper nutrition and training over supplements, noting that while creatine may offer some benefits, “we can get enough protein, aminos, and creatine from our diets – and our bodies actually absorb them best that way.”